Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

SYR-322

Known as: SYR 322, SYR322 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2012
Review
2012
Alogliptin (codenamed SYR-322) is a recently approved anti-diabetic drug in Japan, which has been under clinical development… Expand
Is this relevant?
2009
2009
AIMS Loss of efficacy over time or secondary failure occurs somewhat often and remains a major concern of sulfonylurea (SU… Expand
Is this relevant?